1 / 19

P T Committee Formulary Review Exubera Insulin Human rDNA origin Inhalation Powder

Outline. Overview of P

pilis
Download Presentation

P T Committee Formulary Review Exubera Insulin Human rDNA origin Inhalation Powder

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. P & T Committee Formulary Review Exubera® Insulin Human (rDNA origin) Inhalation Powder Elena Chan PharmD Candidate UCSF Tiffany Jew PharmD, MBA Candidate USC Pro Pharma Pharmaceutical Consultants, Inc

    2. Outline Overview of P&T Committee Formulary Submission Dossier Exubera® – Inhaled Insulin Prior Authorization Criteria

    3. Pharmacy and Therapeutics (P&T) Committee The role of the P&T Committee: Objectively appraises, evaluates, and selects drugs for formulary – value, place in therapy, and impact on budget Manages formulary in light of new drugs, indications, and warnings Develop policies for educating and informing providers about new drugs and committee decisions Quality improvement Develop generic substitution and therapeutic interchange programs Develop procedures for use and access to non-formulary drugs Committee meets regularly throughout the year Members include physicians, pharmacists, administrators, and other health care professionals

More Related